Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer

To overcome difficulties that hampered widespread application of a specific delivery system in cancer gene therapy and to inhibit the growth of solid liver cancer, we utilized a strain of Bifidobacterium longum as a delivery system to transport an endostatin gene that can inhibit growth of tumor. Th...

Full description

Saved in:
Bibliographic Details
Published inCancer gene therapy Vol. 12; no. 2; pp. 133 - 140
Main Authors Fu, Geng-Feng, Li, Xi, Hou, Ya-Yi, Fan, Yan-Rong, Liu, Wen-Hua, Xu, Gen-Xing
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 01.02.2005
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To overcome difficulties that hampered widespread application of a specific delivery system in cancer gene therapy and to inhibit the growth of solid liver cancer, we utilized a strain of Bifidobacterium longum as a delivery system to transport an endostatin gene that can inhibit growth of tumor. The B. longum strain with the endostatin gene (B. longum-En) was taken orally by tumor-bearing nude mice through drencher preparation. The results showed that B. longum-En could strongly inhibit the growth of solid liver tumor in nude mice and prolong the survival time of tumor-bearing nude mice. Furthermore, tumor growth was inhibited more efficiently when the B. longum-En treatment included selenium. Enriching the B. longum-En treatment with selenium improves the activity of NK and T cells and stimulates the activity of IL-2 and TNF-alpha in BALB/c mice. These results suggest that B. longum may be a highly specific and efficient vector for transporting anticancer genes in cancer gene therapy.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0929-1903
1476-5500
DOI:10.1038/sj.cgt.7700758